Yes, top line data only. The benefit (as measured by CGI-I) of NTI164 is the same as FDA approved DAYBUE (-0.3) which is good.
The secondary endpoint data will be instructive - if the side effects of the NTI drug are better than DAYBUE then that may be a selling point.
- Forums
- ASX - By Stock
- Ann: Trading Halt
Yes, top line data only. The benefit (as measured by CGI-I) of...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
|
|||||
Last
8.6¢ |
Change
0.002(2.38%) |
Mkt cap ! $91.56M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.4¢ | $195.8K | 2.205M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 116098 | 8.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 52694 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 39000 | 0.087 |
1 | 116279 | 0.086 |
3 | 186545 | 0.085 |
4 | 126148 | 0.084 |
2 | 150240 | 0.083 |
Price($) | Vol. | No. |
---|---|---|
0.088 | 68273 | 3 |
0.089 | 68384 | 1 |
0.090 | 212500 | 2 |
0.091 | 100000 | 1 |
0.092 | 377100 | 3 |
Last trade - 12.50pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
NTI (ASX) Chart |